BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Baskiran A, Akbulut S, Sahin TT, Koc C, Karakas S, Ince V, Yurdaydin C, Yilmaz S. Effect of HBV-HDV co-infection on HBV-HCC co-recurrence in patients undergoing living donor liver transplantation. Hepatol Int. 2020;14:869-880. [PMID: 32895876 DOI: 10.1007/s12072-020-10085-3] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Rammohan A. Current management & future directions in post-liver transplant recurrence of viral hepatitis. Journal of Liver Transplantation 2021;3:100027. [DOI: 10.1016/j.liver.2021.100027] [Reference Citation Analysis]
2 Zhang Y, Lei X, Xu L, Lv X, Xu M, Tang H. Preoperative and postoperative nomograms for predicting early recurrence of hepatocellular carcinoma without macrovascular invasion after curative resection. BMC Surg 2022;22:233. [PMID: 35715787 DOI: 10.1186/s12893-022-01682-0] [Reference Citation Analysis]
3 Lebray P, Delignat S, Frelicot A, Carrette M, Gautier A, Jamet N, Lecefel C, Houot M, Bourguignon S, Thabut D, Conti F, Liou A. Hepatitis B or Delta liver transplant patients at risk of recurrence: Long-term effectiveness and budget impact of low-dose subcutaneous anti-hepatitis B immunoglobulin plus patient education program. Journal of Liver Transplantation 2022. [DOI: 10.1016/j.liver.2022.100088] [Reference Citation Analysis]
4 Akada K, Koyama N, Miura Y, Aoshima K. Nationwide database analysis of insomnia, depression, and sleeping pill prescriptions in hepatocellular carcinoma patients. Curr Med Res Opin 2022;:1-28. [PMID: 35608320 DOI: 10.1080/03007995.2022.2081451] [Reference Citation Analysis]
5 Pisano MB, Giadans CG, Flichman DM, Ré VE, Preciado MV, Valva P. Viral hepatitis update: Progress and perspectives . World J Gastroenterol 2021; 27(26): 4018-4044 [PMID: 34326611 DOI: 10.3748/wjg.v27.i26.4018] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 4] [Article Influence: 7.0] [Reference Citation Analysis]
6 Xia F, Huang Z, Ndhlovu E, Zhang M, Chen X, Zhang B, Zhu P. The effect of the number of hepatic inflow occlusion times on the prognosis of ruptured hepatocellular carcinoma patients after hepatectomy. BMC Surg 2022;22. [DOI: 10.1186/s12893-022-01537-8] [Reference Citation Analysis]
7 Wu L, Cao H, Tian X, Zheng W, Yuan M, Li X, Tian X, Wang Y, Song H. Bone marrow mesenchymal stem cells modified with heme oxygenase-1 alleviate rejection of donation after circulatory death liver transplantation by inhibiting dendritic cell maturation in rats. International Immunopharmacology 2022;107:108643. [DOI: 10.1016/j.intimp.2022.108643] [Reference Citation Analysis]
8 Baskiran A, Atay A, Baskiran DY, Akbulut S. Hepatitis B/D-Related Hepatocellular Carcinoma. A Clinical Literature Review. J Gastrointest Cancer 2021. [PMID: 34611832 DOI: 10.1007/s12029-021-00714-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
9 Guo J, Ma C, Song X, Tang F, Guo L, Mao J, Li Y. Hepatocellular Carcinoma Complicated by Echinococcal Cyst: A Case Report. Front Surg 2022;8:816501. [DOI: 10.3389/fsurg.2021.816501] [Reference Citation Analysis]